Law Offices of Howard G. Smith announces an investigation on behalf of investors of Solazyme, Inc. (“Solazyme” or the “Company”) (NASDAQ: SZYM), for potential violations of the federal securities laws. Solazyme investors that have lost over $75,000 are encouraged to call Howard G. Smith, Esq. to discuss the alleged wrongdoing, and steps investors can take to recover any losses caused by the Company’s alleged fraud.

Solazyme is a San Francisco-based bioproducts company that produces sustainable oils from microalgae. The Company uses an industrial fermentation process to transform plant-based sugars into triglyceride oils, which are used in a wide range of products. The investigation concerns whether Solazyme made false and/or misleading statements and concealed material information concerning the production capacity of its oil producing facility in Moema, Brazil. Solazyme improperly concealed ongoing construction delays caused by inadequate access to electricity and steam utility services. The diminished capacity of Solazyme’s Brazilian oil facility was made known to the investing public on November 5, 2014, when the Company disclosed that it needed to “narrow [its] production focus to smaller volumes of higher value products.” As a result of this news, shares of Solazyme fell $4.35 per share, or over 58%, to close on November 6, 2014, at $3.14 per share on heavy volume.

If you purchased Solezyme shares, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.